๐ฐ Lipids News
Page 20 - Lipids News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lipids. Real-time updates on events, politics, business and more.
November 8, 2023
Dr. Dragomir Milovanovic, a neuroscientist at DZNE's Berlin site, has been awarded an European Research Council (ERC) "Starting Grant" worth 1.5 million euros to investigate biophysical phenomena relevant to brain diseases in a groundbreaking research project.
November 7, 2023
Even if you struggle to give exercise advice to your patients, this simple starter guide can help (including things NOT to say).
November 7, 2023
The interactions between the gut microbiome, lipids, and Alzheimerโs disease (AD).
November 7, 2023
The association between Mediterranean diet (MD) adherence and lipid profiles among disease-free community residents
November 6, 2023
The prevalence of elevated low-density lipoprotein cholesterol has declined recently, but millions of Americans still have levels for which treatment is recommended or should be considered and many remain untreated.
November 6, 2023
No racial or ethnic disparities in long-term adverse effects or cardiovascular mortality were seen among women with obstructive coronary artery disease treated in university or academic centers.
October 31, 2023
The latest study of statins and diabetes risk points to a small increased risk for new-onset diabetes with rosuvastatin vs atorvastatin, but experts advise caution in interpreting the results.
October 31, 2023
Older patients with higher triglyceride levels, mostly within the normal to high range, had lower risk of dementia and slower cognitive decline over time than those with lower triglyceride levels.
October 27, 2023
A plant-based dietary pattern that includes cholesterol-lowering foods and nutrients is associated with lower risk for cardiovascular disease and stroke, a new study suggests.
October 26, 2023
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.